Publications

  1. Suresh R, Li X, Chiriac A, Goel K, Terzic A, Perez-Terzic C, Nelson TJ. Transcriptome from circulating cells suggests dysregulated pathways associated with long-term recurrent events following first-time myocardial infarction. J Mol Cell Cardiol. 2014 Sep; 74:13-21. Epub 2014 May 04.
    View PubMed
  2. Shanmugasegaram S, Perez-Terzic C, Jiang X, Grace SL. Cardiac rehabilitation services in low- and middle-income countries: a scoping review. J Cardiovasc Nurs. 2014 Sep-Oct; 29(5):454-63.
    View PubMed
  3. Gou S, Oxentenko SC, Eldrige JS, Xiao L, Pingree MJ, Wang Z, Perez-Terzic C, Qu W. Stem Cell Therapy for Intervertebral Disk Regeneration. Am J Phys Med Rehabil. 2014 Aug 13.
    View PubMed
  4. Martinez-Fernandez A, Nelson TJ, Reyes S, Alekseev AE, Secreto F, Perez-Terzic C, Beraldi R, Sung HK, Nagy A, Terzic A. iPS Cell-Derived Cardiogenicity is Hindered by Sustained Integration of Reprogramming Transgenes. Circ Cardiovasc Genet. 2014 Jul 30.
    View PubMed
  5. Alsara O, Perez-Terzic C, Squires RW, Dandamudi S, Miranda WR, Park SJ, Thomas RJ. Is exercise training safe and beneficial in patients receiving left ventricular assist device therapy? J Cardiopulm Rehabil Prev. 2014 Jul-Aug; 34(4):233-40.
    View PubMed
  6. Alsara O, Reeves RK, Pyfferoen MD, Trenary TL, Engen DJ, Vitse ML, Kessler SM, Kushwaha SS, Clavell AL, Thomas RJ, Lopez-Jimenez F, Park SJ, Perez-Terzic CM. Inpatient Rehabilitation Outcomes for Patients Receiving Left Ventricular Assist Device. Am J Phys Med Rehabil. 2014 Jun 04.
    View PubMed
  7. Suresh R, Chiriac A, Goel K, Villarraga HR, Lopez-Jimenez F, Thomas RJ, Terzic A, Nelson TJ, Perez-Terzic C. CXCR4+ and FLK-1+ identify circulating cells associated with improved cardiac function in patients following myocardial infarction. J Cardiovasc Transl Res. 2013 Oct; 6(5):787-97. Epub 2013 Aug 10.
    View PubMed
  8. Folmes CD, Arrell DK, Zlatkovic-Lindor J, Martinez-Fernandez A, Perez-Terzic C, Nelson TJ, Terzic A. Metabolome and metaboproteome remodeling in nuclear reprogramming. Cell Cycle. 2013 Aug 1; 12(15):2355-65. Epub 2013 Jul 08.
    View PubMed
  9. Lopez-Jimenez F, Perez-Terzic C, Zeballos P, Anchique C, Burdiat G, Gonzalez K, Gonzalez G, Fernandez R, Santibanez C, Herdy A, Rodriguez Escudero J, Ilarraza-Lomeli H. Consenso rehabilitacion cardiovascular y prevencion secundaria de las sociedades interamericana y sudamericana de cardiologia. Rev Urug Cardiol. 2013 August; 28(2):189-224.
  10. Faustino RS, Arrell DK, Folmes CD, Terzic A, Perez-Terzic C. Stem cell systems informatics for advanced clinical biodiagnostics: tracing molecular signatures from bench to bedside. Croat Med J. 2013 Aug; 54(4):319-29.
    View PubMed
  11. Folmes CD, Martinez-Fernandez A, Perales-Clemente E, Li X, McDonald A, Oglesbee D, Hrstka SC, Perez-Terzic C, Terzic A, Nelson TJ. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS. Stem Cells. 2013 Jul; 31(7):1298-308.
    View PubMed
  12. Yamada S, Nelson T, Kane G, Martinez-Fernandez A, Crespo-Diaz RJ, Ikeda Y, Terzic C, Terzic A. iPS Cell Intervention Rescues Wall Motion Disparity Achieving Biological Cardiac Resynchronization Post-Infarction. J Physiol. 2013 May 13. [Epub ahead of print]
    View PubMed
  13. Pack QR, Johnson LL, Barr LM, Daniels SR, Wolter AD, Squires RW, Perez-Terzic CM, Thomas RJ. Improving cardiac rehabilitation attendance and completion through quality improvement activities and a motivational program. J Cardiopulm Rehabil Prev. 2013 May-Jun; 33(3):153-9.
    View PubMed
  14. Folmes CD, Martinez-Fernandez A, Faustino RS, Yamada S, Perez-Terzic C, Nelson TJ, Terzic A. Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells. J Cardiovasc Transl Res. 2013 Feb; 6(1):10-21. Epub 2012 Dec 18.
    View PubMed
  15. Cortes-Bergoderi M, Lopez-Jimenez F, Herdy AH, Zeballos C, Anchique C, Santibanez C, Burdiat G, Gonzalez G, Gonzalez K, Finizola B, Fernandez R, Paniagua M, Thomas RJ, Gonzalez-Moreno J, Rodriguez-Escudero JP, Perez-Terzic C. Availability and characteristics of cardiovascular rehabilitation programs in South America. J Cardiopulm Rehabil Prev. 2013 Jan-Feb; 33(1):33-41.
    View PubMed
  16. Yamada S, Arrell DK, Kane GC, Nelson TJ, Perez-Terzic CM, Behfar A, Purushothaman S, Prinzen FW, Auricchio A, Terzic A. Mechanical dyssynchrony precedes QRS widening in ATP-sensitive K(+) channel-deficient dilated cardiomyopathy. J Am Heart Assoc. 2013; 2(6):e000410. Epub 2013 Dec 05.
    View PubMed
  17. Perez-Terzic CM. Exercise in cardiovascular diseases. PM R. 2012 Nov; 4(11):867-73.
    View PubMed
  18. Cortes-Bergoderi M, Thomas RJ, Albuquerque FN, Batsis JA, Burdiat G, Perez-Terzic C, Trejo-Gutierrez J, Lopez-Jimenez F. Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: a systematic review. Rev Panam Salud Publica. 2012 Aug; 32(2):131-9.
    View PubMed
  19. Santibanez C, Perez-Terzic C, Lopez-Jimenez F, Cortes-Bergoderi M, Araya MV, Burdiat G. [Current status of cardiac rehabilitation in Chile]. Rev Med Chil. 2012 May; 140(5):561-8.
    View PubMed
  20. Santibanez C, Perez-Terzic C, Lopez-Jimenez F, Cortes-Bergoderi M, Araya MV, Burdiat G. Current situation of cardiac rehabilitation in Chile. Revista Médica de Chile. 2012; 140(5).
  21. Rodriguez-Escudero J, Perez-Terzic C, Allison T. The history of cardiac rehabilitation: a global vision. Avances Cardiol. 2012; 32(1):23-31.
  22. Anchique CV, Perez-Terzic C, Lopez-Jimenez F, Cortes-Bergoderi M. Estado actual de la rehabilitacion cardiovascular en Colombia (2010). Revista Colombiana de Cardiologia. 2011 Nov-Dec; 18(6):305.
  23. Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C, Terzic A. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011 Aug 3; 14(2):264-71.
    View PubMed
  24. Burdiat G, Perez-Terzic C, Lopez-Jimenez F, Cortes-Bergoderi M, Santibanez C. Current situation of cardiac rehabilitation in Uruguay. Rev Urug Cardiol. 2011; 26:8-15.
  25. Mola A, Perez-Terzic C, Thomas R, Rey M. Cardiovascular disparities: bridging cardiovascular health promotion. US Cardiology. 2011; 8(1):19-23.
  26. Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J, Terzic A. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol. 2010 Aug 24; 56(9):721-34.
    View PubMed
  27. Terzic A, Perez-Terzic C. Channelopathies: decoding disease pathogenesis. Sci Transl Med. 2010 Jul 28; 2(42):42ps37.
    View PubMed
  28. Faustino RS, Chiriac A, Niederlander NJ, Nelson TJ, Behfar A, Mishra PK, Macura S, Michalak M, Terzic A, Perez-Terzic C. Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype. Stem Cells. 2010 Jul; 28(7):1281-91.
    View PubMed
  29. Goel K, Shen J, Wolter AD, Beck KM, Leth SE, Thomas RJ, Squires RW, Perez-Terzic CM. Prevalence of musculoskeletal and balance disorders in patients enrolled in phase II cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2010 Jul-Aug; 30(4):235-9.
    View PubMed
  30. Nelson TJ, Martinez-Fernandez A, Yamada S, Ikeda Y, Perez-Terzic C, Terzic A. Induced pluripotent stem cells: advances to applications. Stem Cells Cloning. 2010 Jan 1; 3:29-37.
    View PubMed
  31. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc. 2009 Oct; 84(10):876-92.
    View PubMed
  32. Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ Res. 2009 Sep 25; 105(7):648-56. Epub 2009 Aug 20.
    View PubMed
  33. Korenfeld Y, Mendoza-Bastidas C, Saavedra L, Montero-Gomez A, Perez-Terzic C, Thomas RJ, Sert-Kuniyoshi F, Vallejos J, Ibanez-Arenas R, Lopez-Jimenez F. Current status of cardiac rehabilitation in Latin America and the Caribbean. Am Heart J. 2009 Sep; 158(3):480-7. Epub 2009 Aug 04.
    View PubMed
  34. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 2009 Aug 4; 120(5):408-16. Epub 2009 Jul 20.
    View PubMed
  35. Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK, Miki T, Seino S, Behfar A, Terzic A. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells. 2008 Oct; 26(10):2644-53. Epub 2008 Jul 31.
    View PubMed
  36. Behfar A, Faustino RS, Arrell DK, Dzeja PP, Perez-Terzic C, Terzic A. Guided stem cell cardiopoiesis: discovery and translation. J Mol Cell Cardiol. 2008 Oct; 45(4):523-9. Epub 2008 Sep 26.
    View PubMed
  37. Baker DJ, Perez-Terzic C, Jin F, Pitel KS, Niederlander NJ, Jeganathan K, Yamada S, Reyes S, Rowe L, Hiddinga HJ, Eberhardt NL, Terzic A, van Deursen JM. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nat Cell Biol. 2008 Jul; 10(7):825-36. Epub 2008 May 30.
    View PubMed
  38. Park S, Lim BB, Perez-Terzic C, Mer G, Terzic A. Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity. J Proteome Res. 2008 Apr; 7(4):1721-8. Epub 2008 Mar 01.
    View PubMed
  39. Faustino RS, Behfar A, Perez-Terzic C, Terzic A. Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biol. 2008; 9(1):R6. Epub 2008 Jan 09.
    View PubMed
  40. Arrell DK, Niederlander NJ, Perez-Terzic C, Chung S, Behfar A, Terzic A. Pharmacoproteomics: advancing the efficacy and safety of regenerative therapeutics. Clin Pharmacol Ther. 2007 Sep; 82(3):316-9. Epub 2007 Aug 01.
    View PubMed
  41. Faustino RS, Nelson TJ, Terzic A, Perez-Terzic C. Nuclear transport: target for therapy. Clin Pharmacol Ther. 2007 Jun; 81(6):880-6. Epub 2007 Apr 18.
    View PubMed
  42. Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S, Puceat M, Niederlander N, Alekseev AE, Zingman LV, Terzic A. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med. 2007 Feb 19; 204(2):405-20. Epub 2007 Feb 05.
    View PubMed
  43. Perez-Terzic C, Faustino RS, Boorsma BJ, Arrell DK, Niederlander NJ, Behfar A, Terzic A. Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4 Suppl 1:S68-76.
    View PubMed
  44. Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4 Suppl 1:S60-7.
    View PubMed
  45. Baker DJ, Jeganathan KB, Malureanu L, Perez-Terzic C, Terzic A, van Deursen JM. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. J Cell Biol. 2006 Feb 13; 172(4):529-40.
    View PubMed
  46. Behfar A, Hodgson DM, Zingman LV, Perez-Terzic C, Yamada S, Kane GC, Alekseev AE, Puceat M, Terzic A. Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair. Ann N Y Acad Sci. 2005 May; 1049:189-98.
    View PubMed
  47. Kane GC, Behfar A, Yamada S, Perez-Terzic C, O'Cochlain F, Reyes S, Dzeja PP, Miki T, Seino S, Terzic A. ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits. Diabetes. 2004 Dec; 53 Suppl 3:S169-75.
    View PubMed
  48. O'Cochlain DF, Perez-Terzic C, Reyes S, Kane GC, Behfar A, Hodgson DM, Strommen JA, Liu XK, van den Broek W, Wansink DG, Wieringa B, Terzic A. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Hum Mol Genet. 2004 Oct 15; 13(20):2505-18. Epub 2004 Aug 18.
    View PubMed
  49. Hodgson DM, Behfar A, Zingman LV, Kane GC, Perez-Terzic C, Alekseev AE, Puceat M, Terzic A. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol. 2004 Aug; 287(2):H471-9.
    View PubMed
  50. Trushina E, Heldebrant MP, Perez-Terzic CM, Bortolon R, Kovtun IV, Badger JD 2nd, Terzic A, Estevez A, Windebank AJ, Dyer RB, Yao J, McMurray CT. Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc Natl Acad Sci U S A. 2003 Oct 14; 100(21):12171-6. Epub 2003 Oct 03.
    View PubMed
  51. Hodgson DM, Zingman LV, Kane GC, Perez-Terzic C, Bienengraeber M, Ozcan C, Gumina RJ, Pucar D, O'Coclain F, Mann DL, Alekseev AE, Terzic A. Cellular remodeling in heart failure disrupts K(ATP) channel-dependent stress tolerance. EMBO J. 2003 Apr 15; 22(8):1732-42.
    View PubMed
  52. Perez-Terzic C, Behfar A, Mery A, van Deursen JMA, Terzic A, Puceat M. Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes. Circ Res. 2003 Mar 7; 92(4):444-52.
    View PubMed
  53. Mery A, Papadimou E, Zeineddine D, Menard C, Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Perez-Terzic C, Terzic A, Puceat M. Commitment of embryonic stem cells toward a cardiac lineage: molecular mechanisms and evidence for a promising therapeutic approach for heart failure. J Muscle Res Cell Motil. 2003; 24(4-6):269-74.
    View PubMed
  54. Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, Seino S, Alekseev AE, Terzic A. Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci U S A. 2002 Oct 1; 99(20):13278-83. Epub 2002 Sep 23.
    View PubMed
  55. Dzeja PP, Bortolon R, Perez-Terzic C, Holmuhamedov EL, Terzic A. Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer. Proc Natl Acad Sci U S A. 2002 Jul 23; 99(15):10156-61. Epub 2002 Jul 15.
    View PubMed
  56. Li J, Puceat M, Perez-Terzic C, Mery A, Nakamura K, Michalak M, Krause KH, Jaconi ME. Calreticulin reveals a critical Ca(2+) checkpoint in cardiac myofibrillogenesis. J Cell Biol. 2002 Jul 08; 158(1):103-13.
    View PubMed
  57. Khurana VG, Perez-Terzic CM, Petersen RC, Krauss WE. Singing paraplegia: a distinctive manifestation of a spinal dural arteriovenous fistula. Neurology. 2002 Apr 23; 58(8):1279-81.
    View PubMed
  58. Perez-Terzic C, Gacy AM, Bortolon R, Dzeja PP, Puceat M, Jaconi M, Prendergast FG, Terzic A. Directed inhibition of nuclear import in cellular hypertrophy. J Biol Chem. 2001 Jun 8; 276(23):20566-71. Epub 2001 Mar 30.
    View PubMed
  59. Perez-Terzic C, Gacy AM, Bortolon R, Dzeja PP, Puceat M, Jaconi M, Prendergast FG, Terzic A. Structural plasticity of the cardiac nuclear pore complex in response to regulators of nuclear import. Circ Res. 1999 Jun 11; 84(11):1292-301.
    View PubMed
  60. Perez-Terzic C, Jaconi M, Stehno-Bittel L. Measurement of intracellular calcium concentration using confocal microscopy. Methods Mol Biol. 1999; 114:75-91.
    View PubMed
  61. Perez-Terzic C, Jaconi M, Clapham DE. Nuclear calcium and the regulation of the nuclear pore complex. Bioessays. 1997 Sep; 19(9):787-92.
    View PubMed
  62. Perez-Terzic C, Stehno-Bittel L, Clapham DE. Nucleoplasmic and cytoplasmic differences in the fluorescence properties of the calcium indicator Fluo-3. Cell Calcium. 1997 Apr; 21(4):275-82.
    View PubMed
  63. Perez-Terzic C, Pyle J, Jaconi M, Stehno-Bittel L, Clapham DE. Conformational states of the nuclear pore complex induced by depletion of nuclear Ca2+ stores. Science. 1996 Sep 27; 273(5283):1875-7.
    View PubMed
  64. Stehno-Bittel L, Krapivinsky G, Krapivinsky L, Perez-Terzic C, Clapham DE. The G protein beta gamma subunit transduces the muscarinic receptor signal for Ca2+ release in Xenopus oocytes. J Biol Chem. 1995 Dec 15; 270(50):30068-74.
    View PubMed
  65. Stehno-Bittel L, Perez-Terzic C, Clapham DE. Diffusion across the nuclear envelope inhibited by depletion of the nuclear Ca2+ store. Science. 1995 Dec 15; 270(5243):1835-8.
    View PubMed
  66. Perez-Terzic CM, Chini EN, Shen SS, Dousa TP, Clapham DE. Ca2+ release triggered by nicotinate adenine dinucleotide phosphate in intact sea urchin eggs. Biochem J. 1995 Dec 15; 312 ( Pt 3):955-9.
    View PubMed
  67. Lopez JR, Perez C, Linares N, Allen P, Terzic A. Hypersensitive response of malignant hyperthermia-susceptible skeletal muscle to inositol 1,4,5-triphosphate induced release of calcium. Naunyn Schmiedebergs Arch Pharmacol. 1995 Oct; 352(4):442-6.
    View PubMed
  68. Lopez JR, Perez C, Alfonzo M, Cordoves G, Linares N, Allen P. Changes in intracellular calcium concentration induced byinositol 1, 4, 5 triphosphate in human malignant hyperthermia skeletal muscle. Life Science Adv. 1994; 12:131-40.
  69. Lopez JR, Perez C, Allen P. Abnormal calcium release induced by inositol 1, 4, 5 triphosphate in malignant hyperthermia skeletal muscle. Minerva Anestiologica. 1994; 60:141-4.
  70. Lopez JR, Perez C, Alfonzo M, Linares N, Cordoves G, Allen P. Probable partecipazione dell'inosilolo 1, 4, 5 trisfosfato nella fisiopatologia dell'ipertermia maligna. Acta Anaesthesiologica Italica. 1993; 44:293-302.
  71. Lopez JR, Perez C, Allen P, Alfonzo M, Linares N. Efecto del inositol 1, 4, 5 trisfosfato sobre la concentration de calcio en musculo esqueletico de sujetos susceptibles al sindrome de hipertermia maligna. Rev Arg Anes. 1992; 50:193-200.